Pharmaceutical companies face increased competition to meet consumer demand, which means tighter and more complex deals with contract manufacturers.
Pfizer, AstraZeneca and Eli Lilly & Co. are dusting off two dozen old drugs that failed to treat one disease but might treat another.
The FDA recently issued a Form 483, which said inspectors found problems in Impax's quality control laboratory.
The Johnson & Johnson antibiotic is able to cure a vast majority of the rare bacterial infections, which could be use as a potential bioterrorism agent.
Medical device maker Hologic Inc. said Monday that it will buy diagnostic test maker Gen-Probe for about $3.72 billion in an all-cash deal.
The company will look to fill positions at its new type 1 diabetes research center in Seattle and at a manufacturing plant in North Carolina.
New CEO Alex Gorsky said one of his short-term priorities is to get "reliable" consumer products back on store shelves.
The bill is the latest in recent years to try to slow down meth production, which uses cold and allergy medicine containing ephedrine or pseudoephedrine.
Antibiotics have saved countless lives in treating a variety of diseases, but some argue their use in meat breeds antibiotic-resistant germs.
Baxter International Inc. will employ about 1,500 people to make plasma-based therapies that treat chronic and life-threatening illnesses.
The European Union's competition regulator says it has approved Johnson & Johnson's $21.3 billion acquisition of Swiss orthopedics maker Synthes.
The justices questioned whether the federal law governing overtime pay should apply to those who try to persuade doctors to prescribe certain drugs.
Unable to produce much-needed vaccines with its limited production capacity, Merck decided to rapidly increase its manufacturing capabilities.
When designing pharmaceutical facilities, there is much to be taken into consideration, and merely throwing up a "bunch of bricks" just doesn't cut it anymore.
The main ingredient in the male baldness treatment Propecia is responsible, the FDA says, for side effects that linger after patients stop taking the drug.
The world's biggest biotech drugmaker will help KAI finish planning late stage trials of its most advanced drug candidate, which helps dialysis patients.
Medical device maker Cook Group has bought an Indianapolis company that specializes in cell and tissue processing and cryopreservation technologies.
The vials are packaged as Altuzan, the Turkish version of Avastin that is not approved for use in the U.S.
Medical device maker Medtronic Inc. has agreed to pay $85 million to resolve a federal class action lawsuit brought by a group of shareholders.
Swiss pharmaceutical company raised its offer for Illumina to $51 cash per share, in a bid to speed up a takeover of the U.S. diagnostics company.
In a recent test, the popular wrinkle remover and spasm suppressant worked better than a placebo as a treatment for an overactive bladder.
The government alleges that a Cypress subsidiary falsely claimed that three skin products carried the FDA's "safe and effective" designation.
An attorney has asked jurors to hold a J&J subsidiary financially liable for allegedly concealing risks associated with its anti-psychotic drug Risperdal.
The first two trials of more than 2,400 lawsuits nationwide accuse the drug, which was made by Pfizer, of causing the patient to commit suicide.